Neglected Tropical Disease Treatment Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028

The global Neglected Tropical Disease Treatment market size is expected to be worth around US$ 1.10 billion by 2028, according to a new report by Vision Research Reports.

The global Neglected Tropical Disease Treatment market size was valued at US$ 1.8 billion in 2020 and is anticipated to grow at a CAGR of 5.10% during forecast period 2021 to 2028.

Growth Factors

According to the data published in the WHO in 2018, T.B. Gambiense is endemic in 24 countries of Central and West Africa. This caused around 98% of reported cases of sleeping sickness. Furthermore, according to the CDC, around 400 people are infected annually by dengue.

Moreover, according to the statistics published in the WHO in 2019, more than 1.5 billion or 24% of the world’s population are infected with soil-transmitted helminthiases. These infections are distributed widely in tropical and subtropical areas majorly occurring in America, sub-Saharan Africa, East Asia, and China.

Presence of pipeline vaccines and drugs is also considered to be one of the major factors driving the market growth over the forecast period. For instance, Bayer AG is developing Nifurtimox (BAYA2502), currently under phase III clinical trials for the treatment of Chagas disease. Furthermore, Johnson & Johnson Services Inc. is developing Bedaquiline 200mg monotherapy regimen which is under phase II clinical trials for the treatment of leprosy and the study is estimated to be completed in 2021.

In addition, Instituto Butantan and Merck & Co., Inc. collaborated to develop vaccines against dengue in 2018. The Instituto Butantan is developing a dengue vaccine candidate in Brazil, TV003, which is in an ongoing Phase III clinical trial. Merck & Co., Inc. will provide funds to Instituto Butantan for its development.

Report Highlights

Based on disease, the NTD treatment market has been classified into dengue, rabies, trachoma, Buruli ulcer, yaws, leprosy, Chagas disease, human African trypanosomiasis (sleeping sickness), leishmaniases, soil-transmitted helminthiases, and others.

Dengue held the largest segment share in 2018 owing to its increasing prevalence. According to data published in the WHO, around 390 million dengue infections are observed per year globally.

Furthermore, based on studies published in the Epidemiological Update Dengue by the WHO and Pan American Health Organization, in 2018, 16 countries and territories in America reported an increase in dengue cases nationally in comparison to 2017 cases. Moreover, in the first 6 weeks of 2019, there were around 99,998 dengue cases reported in America which accounts for 10.2 cases per 100,000 population including 28 deaths.

Buruli ulcer is estimated to be the fastest-growing segment over the forecast period owing to the rising awareness of the disease. For instance, the Global Buruli Ulcer Initiative (GBUI), a partnership initiative of WHO, Member states, donors, research & academic institutions, non-governmental organizations, and others, is dedicated to raising awareness of Buruli ulcer.

The initiative aims to obtain commitments from policymakers, governments, and donors for support & development of health systems of endemic countries and research and control to improve access to early diagnosis and treatment.

Based on product type, the market is segmented into drugs and vaccines. In 2018, drugs were anticipated to be the largest product type segment owing to its cost-effectiveness and patient compliance, especially for oral drug formulations.

Vaccines were estimated to witness the fastest growth over the forecast period due to the presence of pipeline products. For instance, Takeda Pharmaceutical Company Limited is developing a vaccine for dengue, TAK-003 which is currently under phase III. The clinical development program consists of 5 phase III trials which include DEN-304, DEN-305, DEN-314, DEN-301, and DEN-315.

Besides, Merck & Co. Inc., is developing a vaccine for dengue, V180, which is currently under Phase I clinical trial in the U.S. & Australia and is likely to target dengue-endemic Latin America and the Asia Pacific regions.

NTDs are endemic to around 150 countries and have affected people across the globe. The Asia Pacific dominated the neglected tropical disease treatment market in 2018 and is expected to contribute around 31% of the revenue share. High prevalence of NTDs in the region, continuous increase in the GDP rate, and the presence of a huge target population are anticipated to support the market growth.

However, over the forecast period, Latin America is anticipated to witness the fastest growth. Rising awareness and untapped potential for the treatment of patients with NTDs in Latin American countries regarding ways of tackling NTDs are expected to accelerate the growth of this regional market.

Key Players

F. Hoffmann-La Roche Ltd, Bayer AG, GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Eisai Co. Ltd., Sanofi, Astellas Pharma, Takeda Pharmaceutical Company Limited and Gilead Sciences.

Market Segmentation

  • Disease Outlook

    • Dengue

    • Rabies

    • Trachoma

    • Buruli Ulcer

    • Yaws

    • Leprosy

    • Chagas Disease

    • Human African Trypanosomiasis (Sleeping Sickness)

    • Leishmaniases

    • Soil-Transmitted Helminthiases

    • Others

  • Product Type Outlook 

    • Drugs

    • Vaccines

  • Regional Outlook 

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • Japan

      • China

      • India

      • Indonesia

      • Singapore

      • Philippines

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

      • Bolivia

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Nigeria

      • Ghana

      • Zimbabwe

The Neglected Tropical Disease Treatment market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Neglected Tropical Disease Treatment market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Neglected Tropical Disease Treatment market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neglected Tropical Disease Treatment market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Neglected Tropical Disease Treatment market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Neglected Tropical Disease Treatment capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Neglected Tropical Disease Treatment by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Neglected Tropical Disease Treatment market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2028. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Neglected Tropical Disease Treatment market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Neglected Tropical Disease Treatment market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Neglected Tropical Disease Treatment industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The Neglected Tropical Disease Treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Neglected Tropical Disease Treatment market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Neglected Tropical Disease Treatment market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Neglected Tropical Disease Treatment market. These factors have benefited the growth of the global market for Neglected Tropical Disease Treatment. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Neglected Tropical Disease Treatment. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Neglected Tropical Disease Treatment are as follows:

  • Historic Year: 2017-2020
  • Base Year: 2020
  • Forecast Year 2021 to 2028

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2028);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Neglected Tropical Disease Treatment Market, By Disease

7.1.  Neglected Tropical Disease Treatment Market, By Disease, 2021-2028

7.1.1.    Dengue

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Rabies

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Trachoma

7.1.3.1.        Market Revenue and Forecast (2016-2028)

7.1.4.    Buruli Ulcer

7.1.4.1.        Market Revenue and Forecast (2016-2028)

7.1.5.    Yaws

7.1.5.1.        Market Revenue and Forecast (2016-2028)

7.1.6.    Leprosy

7.1.6.1.        Market Revenue and Forecast (2016-2028)

7.1.7.    Chagas Disease

7.1.7.1.        Market Revenue and Forecast (2016-2028)

7.1.8.    Human African Trypanosomiasis (Sleeping Sickness)

7.1.8.1.        Market Revenue and Forecast (2016-2028)

7.1.9.    Leishmaniases

7.1.9.1.        Market Revenue and Forecast (2016-2028)

7.1.10.  Soil-Transmitted Helminthiases

7.1.10.1.      Market Revenue and Forecast (2016-2028)

7.1.11.  Others

7.1.11.1.      Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Neglected Tropical Disease Treatment Market, Product Type

8.1.  Neglected Tropical Disease Treatment Market, Product Type, 2021-2028

8.1.1.    Drugs

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Vaccines

8.1.2.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Neglected Tropical Disease Treatment Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, By Disease (2016-2028)

9.1.2.    Market Revenue and Forecast, Product Type (2016-2028)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.1.3.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.1.4.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, By Disease (2016-2028)

9.2.2.    Market Revenue and Forecast, Product Type (2016-2028)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.2.3.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.2.4.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.2.5.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.2.6.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, By Disease (2016-2028)

9.3.2.    Market Revenue and Forecast, Product Type (2016-2028)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.3.3.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.3.4.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.3.5.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.3.6.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, By Disease (2016-2028)

9.4.2.    Market Revenue and Forecast, Product Type (2016-2028)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.4.3.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.4.4.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.4.5.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.4.6.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, By Disease (2016-2028)

9.5.2.    Market Revenue and Forecast, Product Type (2016-2028)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.5.3.2.        Market Revenue and Forecast, Product Type (2016-2028)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, By Disease (2016-2028)

9.5.4.2.        Market Revenue and Forecast, Product Type (2016-2028)

Chapter 10.  Company Profiles

10.1.              F. Hoffmann-La Roche Ltd

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Bayer AG

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              GlaxoSmithKline plc

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Novartis AG

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Pfizer, Inc.

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Eisai Co. Ltd.

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Sanofi

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Astellas Pharma

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Takeda Pharmaceutical Company Limited

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Gilead Sciences

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers